scholarly article | Q13442814 |
P50 | author | Denise J. Jamieson | Q24846806 |
Daniela Hampel | Q56792692 | ||
Valerie L Flax | Q57860482 | ||
Eric J Daza | Q58841581 | ||
Linda S Adair | Q61791154 | ||
Margaret E Bentley | Q63255217 | ||
Gerald Tegha | Q63255803 | ||
Lindsay H Allen | Q89996595 | ||
Charles Simion Chasela C | Q99552820 | ||
Deborah D Kamwendo | Q114398705 | ||
BAN Study Team | Q114398706 | ||
Athena P. Kourtis | Q39767903 | ||
Charles van der Horst | Q46164894 | ||
P2093 | author name string | Nicole L Davis | |
Amanda Corbett | |||
Charles M van der Horst | |||
Setarah Shahab-Ferdows | |||
P2860 | cites work | Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach | Q26859055 |
Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc | Q28206868 | ||
Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors | Q28279227 | ||
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial | Q29620805 | ||
Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania | Q33957276 | ||
A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok | Q34274719 | ||
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial | Q34604956 | ||
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries | Q34730606 | ||
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial | Q35054638 | ||
International consultation on the criminalization of HIV transmission: 31 October-2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007. | Q53182892 | ||
Vitamin A and beta-carotene concentrations in adults with HIV/AIDS on highly active antiretroviral therapy. | Q54322985 | ||
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline | Q56092268 | ||
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome | Q57832217 | ||
Plasma homocysteine levels in HIV-infected men with and without lipodystrophy | Q61714138 | ||
Serum erythropoietin and transferrin receptor levels in patients with rheumatoid arthritis | Q71808899 | ||
Association between serum vitamin A and E levels and HIV-1 disease progression | Q73236639 | ||
Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients | Q73366894 | ||
Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy | Q73794457 | ||
Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy | Q73848643 | ||
Vitamin B-12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B-12 status | Q78829977 | ||
Predictive factors of hyperhomocysteinemia in HIV-positive patients | Q79462677 | ||
Micronutrient status during lactation in HIV-infected and HIV-uninfected South African women during the first 6 mo after delivery | Q79512584 | ||
Serum transferrin receptor | Q82098080 | ||
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings | Q35154069 | ||
Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding | Q35863995 | ||
Use of lipid-based nutrient supplements by HIV-infected Malawian women during lactation has no effect on infant growth from 0 to 24 weeks | Q36030214 | ||
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells | Q36277573 | ||
Micronutrient interventions and HIV infection: a review of current evidence | Q36687056 | ||
Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy | Q36729864 | ||
Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen | Q37166538 | ||
Plasma homocysteine is not associated with HIV serostatus or antiretroviral therapy in women | Q37371453 | ||
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi | Q37464854 | ||
Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania | Q39000962 | ||
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. | Q39540055 | ||
HIV-protease inhibitors alter retinoic acid synthesis | Q40774776 | ||
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the ran | Q42217198 | ||
Effect of highly active antiretroviral therapy on homocysteine plasma concentrations in HIV-1-infected patients. | Q42469539 | ||
Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. | Q42539157 | ||
Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial | Q43037005 | ||
Anemia in HIV-infected patients receiving highly active antiretroviral therapy | Q43460970 | ||
Effect of dietary intake and protease inhibitors on serum vitamin B12 levels in a cohort of human immunodeficiency virus-positive patients | Q43584465 | ||
Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy | Q43635513 | ||
Hyperhomocysteinaemia and folate deficiency in human immunodeficiency virus-infected children | Q43818049 | ||
Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression | Q43945339 | ||
Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial | Q43945681 | ||
Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania | Q43945858 | ||
Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania | Q43948278 | ||
Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality | Q43950013 | ||
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. | Q44585706 | ||
Highly active antiretroviral therapy associated with improved anemia among HIV-infected women | Q44684050 | ||
Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort | Q44687903 | ||
HIV-1 infection in women is associated with severe nutritional deficiencies | Q44737848 | ||
Cobalamin deficiency in patients infected with the human immunodeficiency virus. | Q45751498 | ||
Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus | Q45787602 | ||
Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study | Q46231235 | ||
Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response | Q46867188 | ||
HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe | Q46867242 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 1950-1957 | |
P577 | publication date | 2015-07-08 | |
P1433 | published in | Journal of Nutrition | Q3186931 |
P1476 | title | Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women | |
P478 | volume | 145 |
Q90003321 | Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review |
Q33587212 | Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults |
Q41678904 | Elements of kitchen toxicology to exploit the value of traditional (African) recipes: The case of Egusi Okra meal in the diet of HIV+/AIDS subjects |
Q38851708 | Food insecurity, but not HIV-infection status, is associated with adverse changes in body composition during lactation in Ugandan women of mixed HIV status |
Q88916566 | Overview of Nutrients in Human Milk |
Q57255341 | Selenium, Selenoproteins, and Immunity |
Q40076034 | The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers |
Search more.